神州细胞
(688520)
| 流通市值：154.58亿 | | | 总市值：163.25亿 |
| 流通股本：4.45亿 | | | 总股本：4.70亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 659,391,620.12 | 323,190,678.39 | 1,560,152,996.71 | 1,311,881,128.84 |
| 营业收入 | 659,391,620.12 | 323,190,678.39 | 1,560,152,996.71 | 1,311,881,128.84 |
| 二、营业总成本 | 969,406,537.29 | 472,019,007.38 | 2,075,196,015.13 | 1,491,402,986.03 |
| 营业成本 | 63,923,311.12 | 33,718,805.2 | 107,677,220.44 | 77,530,046.99 |
| 税金及附加 | 5,360,743.49 | 2,515,188.29 | 13,405,900.94 | 10,387,466.23 |
| 销售费用 | 374,076,726.72 | 196,959,180.82 | 843,076,444.55 | 628,510,651.19 |
| 管理费用 | 102,033,655.06 | 45,651,187.27 | 187,212,281.06 | 124,665,441.74 |
| 研发费用 | 388,298,901.71 | 171,395,414.91 | 837,852,488.89 | 581,824,568.34 |
| 财务费用 | 35,713,199.19 | 21,779,230.89 | 85,971,679.25 | 68,484,811.54 |
| 其中:利息费用 | 35,671,060.92 | 21,882,614.89 | 83,830,964.16 | 65,898,999.41 |
| 其中:利息收入 | 1,148,944.57 | -469,276.15 | 1,881,707.65 | 1,407,568.62 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -6,667,126.34 | -1,084,047.81 | 10,323,313.36 | 14,081,917.44 |
| 加:投资收益 | 1,262,830.55 | 533,238.55 | 1,253,907.51 | 734,251.04 |
| 资产处置收益 | - | - | 5,814.16 | - |
| 资产减值损失(新) | -12,406,663.68 | -7,872,216.39 | -19,642,764.22 | -11,836,997.31 |
| 信用减值损失(新) | 2,879,968.67 | 4,031,475.03 | -4,823,022.32 | -6,268,772.81 |
| 其他收益 | 8,065,756.73 | 4,579,895.53 | 91,576,709.54 | 16,721,120.17 |
| 四、营业利润 | -316,880,151.24 | -148,639,984.08 | -436,349,060.39 | -166,090,338.66 |
| 加:营业外收入 | 27,372.14 | 17,215.4 | 100,222,129.08 | 100,036,158.09 |
| 减:营业外支出 | 62,082,110.75 | 32,953,177.12 | 227,494,426.06 | 185,225,421.1 |
| 五、利润总额 | -378,934,889.85 | -181,575,945.8 | -563,621,357.37 | -251,279,601.67 |
| 减:所得税费用 | -1,734,126.76 | -291,970.86 | 2,580,828.34 | - |
| 六、净利润 | -377,200,763.09 | -181,283,974.94 | -566,202,185.71 | -251,279,601.67 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | -377,200,763.09 | -181,283,974.94 | -566,202,185.71 | -251,279,601.67 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | -365,692,359.54 | -175,685,454.77 | -564,852,296.49 | -250,672,332.75 |
| 少数股东损益 | -11,508,403.55 | -5,598,520.17 | -1,349,889.22 | -607,268.92 |
| 扣除非经常损益后的净利润 | -316,259,455.9 | -147,501,663.75 | -545,373,538.18 | -200,303,428.99 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | -0.83 | -0.41 | -1.32 | -0.6 |
| (二)稀释每股收益 | -0.83 | -0.41 | -1.32 | -0.6 |
| 八、其他综合收益 | 90,405.65 | -772,094.69 | 134,911.37 | 92,768.44 |
| 归属于母公司股东的其他综合收益 | 87,449.38 | -746,847.19 | 134,574.09 | 92,536.52 |
| 九、综合收益总额 | -377,110,357.44 | -182,056,069.63 | -566,067,274.34 | -251,186,833.23 |
| 归属于母公司股东的综合收益总额 | -365,604,910.16 | -176,432,301.96 | -564,717,722.4 | -250,579,796.23 |
| 归属于少数股东的综合收益总额 | -11,505,447.28 | -5,623,767.67 | -1,349,551.94 | -607,037 |
| 公告日期 | 2026-08-29 | 2026-04-30 | 2026-04-23 | 2025-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |